(6-Methoxypyridin-3-yl)methanamine dihydrochloride is primarily used in pharmaceutical research and development as a key intermediate in the synthesis of biologically active compounds. It is often employed in the creation of molecules that target specific receptors or enzymes, particularly in the central nervous system. The compound's structure allows it to act as a building block for drugs aimed at treating neurological disorders, such as depression, anxiety, or neurodegenerative diseases. Additionally, it is utilized in medicinal chemistry for the design of novel therapeutic agents due to its potential to enhance drug efficacy and selectivity. Its role in drug discovery highlights its importance in advancing treatments for complex medical conditions.